Interventions for Tuberculosis Control and Elimination 2002

1038. Akhtar AJ, Crompton GK, Schonell ME. Para-aminosalicylic acid as a cause
of intestinal malabsorption. Tubercle 1968; 49: 328-31.
1039. Longstreth GF, Newcomer AD, Westbrook PR. Para-aminosalicylic acid-induced
malabsorption. Am J Dig Dis 1972; 17: 731-4.
1040. Wurzel HA, Mayock RL. Thrombocytopenia induced by sodium para-aminosalicylic
acid. Report of a case. JAMA 1953; 153: 1094-5.
1041. Eisner EV, Kasper K. Immune thrombocytopenia due to a metabolite of paraaminosalicylic
acid. Am J Med 1972; 53: 790-6.
1042. Feigin RD, Zarkowsky HF, Shearer W, Anderson DC. Thrombocytopenia following
administration of para-aminosalicylic acid.
1973; 83: 502-3.
(Correspondence). J Pediatr
1043. Kreukniet J, Blom van Assendelft PM, Mouton RP, Tassman A, Bangma PJ.
The influence of para-aminosalicylic acid on isonicotinic acid hydrazide blood
level after oral and intravenous administration.
236-43.
Scand J Respir Dis 1967; 47:
1044. Hanngren Å, Borgå, Sjöqvist F. Inactivation of isoniazid (INH) in Swedish
tuberculosis patients before and during treatment with para-aminosalicylic acid
(PAS). Scand J Respir Dis 1970; 51: 61-9.
1045. Tuberculosis Chemotherapy Centre Madras. A controlled comparison of two
fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary
tuberculosis. Tubercle 1973; 54: 23-45.
1046. Dandona P, Greenbury E, Becket AG. Para-aminosalicylic acid-induced hypoglycemia
in a patient with diabetic nephropathy. Postgrad Med 1980; 56: 135-6.
1047. Lalonde RG, Barkun J. Prolonged ciprofloxacin therapy fails to prevent reactivation
tuberculosis. Clin Infect Dis 1998; 27: 913-4.
1048. Zhao BY, Pine R, Domagala J, Drlica K. Fluoroquinolone action against clinical
isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group
on survival in liquid media and in human macrophages.
Chemother 1999; 43: 661-6.
Antimicrob Agents
1049. Mitchison DA. Early bactericidal activity and sterilizing activity of ciprofloxycin
in pulmonary tuberculosis. (Correspondence).
151: 921.
Am J Respir Crit Care Med 1995;
1050. Gillespie SH, Kennedy N. Early bactericidal activity and sterilizing activity of
ciprofloxacin in pulmonary tuberculosis. (Correspondence).
Care Med 1995; 151: 921-2.
Am J Respir Crit
1051. Yew WW, Piddock LJV, Li MSK, Lyon D, Chan CY, Cheng AFB. In-vitro
activity of quinolones and macrolides against mycobacteria.
Chemother 1994; 34: 343-51.
J Antimicrob
1052. Honeybourne D, Wise R, Andrews JM. Ciprofloxacin penetration into lungs.
(Correspondence). Lancet 1987; 1: 1040.
239